These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
554 related items for PubMed ID: 26818764
1. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease. Kadota T, Matsui H, Hirose T, Suzuki J, Saito M, Akaba T, Kobayashi K, Akashi S, Kawashima M, Tamura A, Nagai H, Akagawa S, Kobayashi N, Ohta K. BMC Infect Dis; 2016 Jan 27; 16():31. PubMed ID: 26818764 [Abstract] [Full Text] [Related]
7. The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study. Hosono Y, Kitada S, Yano Y, Mori M, Miki K, Miki M, Yoshimura K, Kagawa H, Oshitani Y, Yokota S. J Infect Chemother; 2018 May 15; 24(5):353-357. PubMed ID: 29361415 [Abstract] [Full Text] [Related]
9. Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: a propensity score analysis. Komiya K, Kurashima A, Ihi T, Nagai H, Matsumoto N, Mizunoe S, Ishii H, Takahashi O, Ohta K, Kudoh S, Kadota J. Int J Antimicrob Agents; 2014 Aug 15; 44(2):131-5. PubMed ID: 24948577 [Abstract] [Full Text] [Related]
10. Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease. Wallace RJ, Brown-Elliott BA, McNulty S, Philley JV, Killingley J, Wilson RW, York DS, Shepherd S, Griffith DE. Chest; 2014 Aug 15; 146(2):276-282. PubMed ID: 24457542 [Abstract] [Full Text] [Related]
11. The clinical efficacy of a clarithromycin-based regimen for Mycobacterium avium complex disease: A nationwide post-marketing study. Kadota JI, Kurashima A, Suzuki K. J Infect Chemother; 2017 May 15; 23(5):293-300. PubMed ID: 28254517 [Abstract] [Full Text] [Related]
14. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. Jeong BH, Jeon K, Park HY, Kim SY, Lee KS, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ. Am J Respir Crit Care Med; 2015 Jan 01; 191(1):96-103. PubMed ID: 25393520 [Abstract] [Full Text] [Related]
15. Minimum inhibitory concentrations of azithromycin in clinical isolates of Mycobacterium avium complex in Japan. Uwamino Y, Aoki W, Inose R, Kamoshita Y, Mikita K, Namkoong H, Nishimura T, Matsushita H, Hasegawa N. Microbiol Spectr; 2024 Jun 04; 12(6):e0021824. PubMed ID: 38687080 [Abstract] [Full Text] [Related]
16. Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period. Kobashi Y, Abe M, Mouri K, Obase Y, Kato S, Oka M. J Infect Chemother; 2012 Aug 04; 18(4):436-43. PubMed ID: 22205543 [Abstract] [Full Text] [Related]
20. [Clinical features and treatment history of clarithromycin resistance in M. avium-intracellulare complex pulmonary disease patients]. Kuwabara K, Tsuchiya T. Nihon Kokyuki Gakkai Zasshi; 2007 Aug 04; 45(8):587-92. PubMed ID: 17763685 [Abstract] [Full Text] [Related] Page: [Next] [New Search]